Levosimendan in daily intensive care practice--the experience of 15 centers. Background, methods and organization of the PORTLAND study
{{output}}
Introduction: The LIDO and RUSSLAN trials showed that levosimendan was well tolerated and had a stronger hemodynamic effect than dobutamine and a positive impact on prognosis. There are, however, few data regarding its effectiven... ...
